Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
P., Brouwers B., Wu Q., Thomas M
Consistent with the base-case analysis, sensitivity analyses demonstrated that using GLP-1RAs versus insulin was either cost-saving or cost-effective, except for the analyses where the treatment effectiveness was estimated based on the AT scenario in the second and third sensitivity analyses, showing that a GLP-1RA versus insulin therapy was not cost-effective for averting one case of all-cause death from the payer perspective
Ipamorelin, CID 9831659
Table of Contents: What are GLP-1 medications
However, effectiveness can vary due to absorption differences
US$ 22.27
US$ 23.21
US$ 25.77
US$ 28.43
US$ 26.58
US$ 22.16
US$ 25.94
US$ 25.16
US$ 21.74
